Advanced 3D Lung Organoid Models for Respiratory Research
At Ace Therapeutics, we understand that the translational gap in respiratory drug development often lies in the limitations of traditional 2D culture systems. While animal models provide systemic context, they do not always recapitulate human-specific pathophysiology. Our 3D Lung Organoid Models and Analysis Services bridge this gap, providing a physiologically relevant, human-cell-based platform to assess drug efficacy, toxicity, and disease mechanisms.
Lung organoids are miniaturized, self-assembled 3D structures derived from primary human epithelial cells or iPSCs. They recapitulate the key architectural and functional features of native lung tissue, including the presence of multiple cell types (basal, club, ciliated, and ATII cells) within a polarized epithelium.
Unlike standard monolayer cultures, our 3D models exhibit:
We offer a comprehensive suite of models designed to address various respiratory indications. All models can be customized regarding cell sources (healthy vs. diseased donors) and culture durations.
| Model Type | Tissue Origin | Primary Applications |
| Airway Lung Organoids | Bronchial/Tracheal Epithelium | Asthma, COPD, Cystic Fibrosis, viral infections. |
| Alveolar Lung Organoids | Alveolar Epithelial Cells (ATII) | IPF, alveolar regeneration, surfactant deficiency, acute lung injury. |
| Disease-Specific Models | Cells from defined patient cohorts | Phenotypic assays for rare genetic disorders or specific endotypes. |
Recognizing that every drug candidate is unique, we emphasize customization. Our team works closely with your scientists to develop fit-for-purpose models. Key customization parameters include:
A model is only as valuable as the data it produces. We offer a full spectrum of analytical services to extract maximum biological insight from your organoid studies.
Efficacy Testing
Toxicity Screening
Genomic & Proteomic Analysis
Move beyond flat biology. Let Ace Therapeutics help you navigate the complexities of respiratory disease with our cutting-edge 3D Lung Organoid services.
What is the difference between airway organoids and alveolar organoids?
Airway organoids are derived from bronchial tissue and contain basal, ciliated, and secretory cells, making them ideal for studying obstructive diseases. Alveolar organoids focus on the distal lung, containing ATII and ATI-like cells, which are crucial for understanding fibrosis and gas exchange interface pathology.
Can you generate organoids from my specific cell lines or patient samples?
Yes. We specialize in custom model development. If you have specific cell lines or de-identified patient samples, we can incorporate them into our workflow to generate bespoke 3D models that reflect your population of interest.
Do you offer co-culture models with immune cells?
Absolutely. We can establish co-culture systems where immune cells (e.g., macrophages or T-cells) are integrated into the organoid platform to facilitate studies on inflammatory responses and immuno-modulatory drug candidates.
What types of readouts are available for fibrosis models?
For fibrotic models, we typically assess extracellular matrix remodeling through second harmonic generation imaging, quantification of soluble collagen, and immunohistochemical staining for markers like α-SMA and Fibronectin. Functional readouts also include the measurement of matrix stiffness where applicable.
How do you ensure the reproducibility of the organoid cultures?
We utilize defined media formulations, strict passage controls, and validated cell sources. Each batch is characterized for key phenotypic markers before study initiation to ensure baseline consistency across experimental replicates.
Make Order
Experimental Scheme
Implementation
Conclusion
Ace Therapeutics is a preclinical research organization focused on respiratory diseases. We provide validated models and rigorous analysis services to support the development of novel therapeutics, from concept to preclinical insight.